Literature DB >> 2689344

Prevalence of pertussis IgG antibodies in children in Palermo, Italy.

T Stroffolini1, A Giammanco, L De Crescenzo, F Lupo, V Nicosia, G Torres, A R Valenza, A Cascio, S Taormina, L Nisticò.   

Abstract

The prevalence of IgG antibodies to Bordetella pertussis in a sample of 615 1-12-year-old unvaccinated children in Palermo was estimated by ELISA. The overall prevalence was 56%; it increased from 24% in one to three-year-old children to 67% in 11-12-year-old children (p less than 0.01). IgG antibody prevalence was not associated with the father's years of schooling (OR 1), nor with the family size (OR 1.3; C.I. 95% = 0.8-2.2). For children aged one the three years, serological results showed that the history of pertussis reported by parents in questionnaires gave high specificity (93.2%) and negative predictive value (85.4%). Our seroepidemiological study evidences a great exposure of children to B. pertussis in Palermo, with a high proportion of infections occurring after three years of age.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689344     DOI: 10.1007/bf01650708

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  Can whooping cough be eradicated?

Authors:  P L Kendrick
Journal:  J Infect Dis       Date:  1975-12       Impact factor: 5.226

2.  Whooping cough and its epidemiological anomalies.

Authors:  J E GORDON; R I HOOD
Journal:  Am J Med Sci       Date:  1951-09       Impact factor: 2.378

3.  The efficiency of measles and pertussis notification in England and Wales.

Authors:  J A Clarkson; P E Fine
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

4.  Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay.

Authors:  G Zackrisson; I Krantz; T Lagergård; P Larsson; R Sekura; N Sigurs; J Taranger; B Trollfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

5.  Serum IgA antibody to Bordetella pertussis as an indicator of infection.

Authors:  J Nagel; E J Poot-Scholtens
Journal:  J Med Microbiol       Date:  1983-11       Impact factor: 2.472

6.  Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay.

Authors:  M Granström; A A Lindberg; P Askelöf; B Hederstedt
Journal:  J Med Microbiol       Date:  1982-02       Impact factor: 2.472

7.  Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA).

Authors:  M K Viljanen; O Ruuskanen; C Granberg; T T Salmi
Journal:  Scand J Infect Dis       Date:  1982

8.  Immunization coverage in Italy.

Authors:  S Salmaso; M A Stazi; S Luzi; D Greco
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

9.  Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.

Authors:  D G Burstyn; L J Baraff; M S Peppler; R D Leake; J St Geme; C R Manclark
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  An enzyme-linked-immunosorbent assay method for detection of immunoglobulins to pertussis toxin.

Authors:  G Zackrisson; T Lagergård; I Lönnroth
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1986-12
View more
  3 in total

1.  Rapid immunodot technique for identifying Bordetella pertussis.

Authors:  G N Sanden; P K Cassiday; J M Barbaree
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

Review 2.  Which strategy for pertussis vaccination today?

Authors:  Dorota Z Girard
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Seroepidemiology of pertussis infection in an urban childhood population in Cameroon.

Authors:  T Stroffolini; A Giammanco; A Chiarini; S Taormina; A Sarzana; G Mazza; M Maggio; M Chiaramonte; T Ngatchu; D Lantum
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.